The ferritin level at which iron therapy is indicated differs between pregnancy and non-pregnancy. The Swiss expert letter from the SGGG sets this level at 30 µg/l during pregnancy, regardless of the hemoglobin level [1]. The Swiss general practice guideline states that, outside of pregnancy, in cases of iron deficiency without anemia, treatment is only considered an indication on a case-by-case basis when levels fall below 15 ng/ml [3]. The following article compares these two situations side by side.
Autoren
- Jens Dehn
Publikation
- GYNÄKOLOGIE PRAXIS
Related Topics
You May Also Like
- Breast (HR+) and Endometrial Cancer
A Comparison of Hormone-Dependent Female Tumors
- Chronic Urticaria: Treatment for Patients Unresponsive to Antihistamines
In addition to anti-IgE antibodies, the guideline recommends anti-IL-4α antibodies and BTK inhibition
- Type 1 Diabetes in Childhood
Early Impairment of Glucagon Counterregulation
- Psychosis in Parkinson's Disease
Be Careful When Choosing Medications
- Esophageal Cancer
A Comparison of Endoscopic and Surgical Innovations
- PMR and LVV: Current EULAR Recommendations
Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis
- Cellular and Systemic Iron Homeostasis
“Steady State” – a delicately balanced equilibrium
- Psychedelic-assisted therapy